Story perspectives

Nvidia Partners Abridge to Automate Doctor Notes with AI.

6/12/2026

Summary

**Nvidia Partners Abridge**

Nvidia announced a partnership with Abridge to build an AI model for physician-patient conversations.
The model will be trained on Nvidia’s Nemotron open-source suite and run only on Abridge’s platform.
Nvidia’s $5.3 billion stake in Abridge after a $300 million raise was reflected in shares near $137 on June 11 2026.
Dr. Joon Lee expects the system, which will automate documentation and verify billing codes before year-end 2026, to aid over 3,000 clinicians.

Summary

**Eli Lilly Backs**

Eli Lilly invested strategically in Abridge to accelerate clinical-trial enrollment.
Abridge’s funding totals $1.1 billion, with a $316 million Series E in April 2026 that valued it at $5.3 billion.
The ambient-AI market reached $7.24 billion in 2025 and is projected to hit $56.61 billion by 2035.
Continuous audio capture triggers new security assessments, patient consent and business-associate agreements.
AI-generated notes that bypass physician review become records, raising liability as the system expands into billing and orders.

1 of 2

**Nvidia Partners Abridge**

Nvidia announced a partnership with Abridge to build an AI model for physician-patient conversations.
The model will be trained on Nvidia’s Nemotron open-source suite and run only on Abridge’s platform.
Nvidia’s $5.3 billion stake in Abridge after a $300 million raise was reflected in shares near $137 on June 11 2026.
Dr. Joon Lee expects the system, which will automate documentation and verify billing codes before year-end 2026, to aid over 3,000 clinicians.

1 / 2